title: The trouble with dabigatran.
authors: Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.
authors: Blake
authors: B
authors: Charlton
authors: Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA redberg@medicine.ucsf.edu.
authors: Rita
authors: R
authors: Redberg
mesh_terms: D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood*; D000069604:Dabigatran; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D016903:Drug Monitoring; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D011358:Product Surveillance, Postmarketing; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran